Geographic Atrophy
-
Subject Areas on Research
- (Pro)renin receptor is expressed in human retinal pigment epithelium and participates in extracellular matrix remodeling.
- Abundance of infiltrating CD163+ cells in the retina of postmortem eyes with dry and neovascular age-related macular degeneration.
- Accuracy of international classification of diseases, ninth revision, clinical modification billing codes for common ophthalmic conditions.
- Analysis of Peripapillary Atrophy in Relation to Macular Geographic Atrophy in Age-Related Macular Degeneration.
- C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration: A Randomized Pivotal Phase 2/3 Trial.
- Comparison of color fundus photographs and fundus autofluorescence images in measuring geographic atrophy area.
- Consensus Definition for Atrophy Associated with Age-Related Macular Degeneration on OCT: Classification of Atrophy Report 3.
- Development and Course of Scars in the Comparison of Age-Related Macular Degeneration Treatments Trials.
- Effect of Anti-C5a Therapy in a Murine Model of Early/Intermediate Dry Age-Related Macular Degeneration.
- Efficacy and Safety of Lampalizumab for Geographic Atrophy Due to Age-Related Macular Degeneration: Chroma and Spectri Phase 3 Randomized Clinical Trials.
- Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials.
- Fundus autofluorescence imaging in age-related macular degeneration and geographic atrophy.
- Heritability and genome-wide association study to assess genetic differences between advanced age-related macular degeneration subtypes.
- Imaging Features Associated with Progression to Geographic Atrophy in Age-Related Macular Degeneration: Classification of Atrophy Meeting Report 5.
- Imaging Protocols in Clinical Studies in Advanced Age-Related Macular Degeneration: Recommendations from Classification of Atrophy Consensus Meetings.
- Impact of Baseline Characteristics on Geographic Atrophy Progression in the FILLY Trial Evaluating the Complement C3 Inhibitor Pegcetacoplan.
- Incidence and Growth of Geographic Atrophy during 5 Years of Comparison of Age-Related Macular Degeneration Treatments Trials.
- Incidence and Progression of Nongeographic Atrophy in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Clinical Trial.
- Incidence of Age-Related Macular Degeneration in a Multi-Ethnic United States Population: The Multi-Ethnic Study of Atherosclerosis.
- Interferon gamma-inducible protein-10 (IP-10) and eotaxin as biomarkers in age-related macular degeneration.
- Local Anatomic Precursors to New-Onset Geographic Atrophy in Age-Related Macular Degeneration as Defined on OCT.
- Long-term Evolution and Remodeling of Soft Drusen in Rhesus Macaques.
- Longitudinal Study of Visual Function in Dry Age-Related Macular Degeneration at 12 Months.
- Longitudinal analysis of reticular drusen associated with geographic atrophy in age-related macular degeneration.
- Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials.
- Natural History of Geographic Atrophy Progression Secondary to Age-Related Macular Degeneration (Geographic Atrophy Progression Study).
- Natural history of central sparing in geographic atrophy secondary to non-exudative age-related macular degeneration.
- Near-Infrared Reflectance Imaging for Quantification of Atrophy Associated with Age-Related Macular Degeneration.
- OCT Signs of Early Atrophy in Age-Related Macular Degeneration: Interreader Agreement: Classification of Atrophy Meetings Report 6.
- Optical Coherence Tomography Predictors of Risk for Progression to Non-Neovascular Atrophic Age-Related Macular Degeneration.
- Optical Coherence Tomography Reflective Drusen Substructures Predict Progression to Geographic Atrophy in Age-related Macular Degeneration.
- PROGRESSION OF MACULAR ATROPHY IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION UNDERGOING ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY.
- Peripheral Retinal Changes Associated with Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 12 by the Age-Related Eye Disease Study 2 Optos PEripheral RetinA (OPERA) Study Research Group.
- Progression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16.
- Randomized Trial to Evaluate Tandospirone in Geographic Atrophy Secondary to Age-Related Macular Degeneration: The GATE Study.
- Relationship of Topographic Distribution of Geographic Atrophy to Visual Acuity in Nonexudative Age-Related Macular Degeneration.
- Relationship of central choroidal thickness with age-related macular degeneration status.
- Reticular drusen associated with geographic atrophy in age-related macular degeneration.
- Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.
- Semiautomated image processing method for identification and quantification of geographic atrophy in age-related macular degeneration.
- Semiautomatic Segmentation of Rim Area Focal Hyperautofluorescence Predicts Progression of Geographic Atrophy Due to Dry Age-Related Macular Degeneration.
- Subretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments Trials.
- The ARMS2 A69S variant and bilateral advanced age-related macular degeneration.
- Therapeutic Options Under Development for Nonneovascular Age-Related Macular Degeneration and Geographic Atrophy.
- Use of fundus autofluorescence images to predict geographic atrophy progression.
- Validated automatic segmentation of AMD pathology including drusen and geographic atrophy in SD-OCT images.
- Visual Acuity Screening Among Asymptomatic Older Adults.
- Visual Function Decline Resulting from Geographic Atrophy: Results from the Chroma and Spectri Phase 3 Trials.
- Visual Function Metrics in Early and Intermediate Dry Age-related Macular Degeneration for Use as Clinical Trial Endpoints.
- Vitamin D deficiency in neovascular versus nonneovascular age-related macular degeneration.
-
Keywords of People
- Farsiu, Sina, Professor in the Department of Biomedical Engineering, Electrical and Computer Engineering
- Stinnett, Sandra Sue, Associate Professor of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics
- Toth, Cynthia Ann, Joseph A.C. Wadsworth Distinguished Professor of Ophthalmology, Biomedical Engineering